NCT05615909View on ClinicalTrials.gov

PRO-MR-RT Systematic Patient-reported Outcomes to Pelvic Online MRgRT

CompletedOBSERVATIONAL
Enrollment

156

Participants

Timeline

Start Date

November 19, 2020

Primary Completion Date

June 30, 2023

Study Completion Date

December 31, 2023

Conditions
Prostate Cancer
Interventions
RADIATION

Online MR-guided radiotherapy

Online adaptive MR-guided radiotherapy in the Unity MR-linac for localized intermediate risk prostate cancer (60 Gy/20 fx) or low-volume metastatic prostate cancer (36 Gy/6 fx).

RADIATION

CT-guided radiotherapy

CT-guided radiotherapy in linear accelerators for patients with high-risk prostate cancer (78 Gy/39 fx), intermediate risk prostata cancer (60 Gy/20 Fx) or having salvage radiotherapy (70 Gy/35 fx)

Trial Locations (1)

5000

Odense University Hospital, Odense

Sponsors

Collaborators (1)

Novo Nordisk A/S
All Listed Sponsors
collaborator

Novo Nordisk A/S

INDUSTRY

collaborator

AgeCare Academy of Geriatric Cancer Research

UNKNOWN

lead

Odense University Hospital

OTHER